DiaMedica Therapeutics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • DiaMedica Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $771K, a 74% increase year-over-year.
  • DiaMedica Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $2.79M, a 54.1% increase year-over-year.
  • DiaMedica Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2024 was $2.09M, a 23.9% increase from 2023.
  • DiaMedica Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.68M, a 12.1% increase from 2022.
  • DiaMedica Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.5M, a 3.59% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.09M +$402K +23.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 $1.68M +$181K +12.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $1.5M -$56K -3.59% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $1.56M -$285K -15.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $1.84M +$679K +58.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $1.16M +$544K +87.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
2018 $620K +$211K +51.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
2017 $409K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.